Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-Menopausal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01791478
What this trial is testing

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerInvasive Ductal Breast Carcinoma+3 more
Vanderbilt-Ingram Cancer Center 46
Not applicableStudy completedNCT02291315
What this trial is testing

Calcium Absorption in Postmenopausal Thai Women

Who this might be right for
Fractional Calcium Absorption
Cornell University 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03841058
What this trial is testing

Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Who this might be right for
Spinal Fusion
Hospital for Special Surgery, New York 96
Early research (Phase 1)Study completedNCT03436849
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESN364 in Healthy Japanese Male and Pre- and Post-menopausal Female Subjects

Who this might be right for
Healthy Subjects
Astellas Pharma Inc 44
Testing effectiveness (Phase 2)Study completedNCT00172107
What this trial is testing

Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Shire 217
Early research (Phase 1)WithdrawnNCT06970405
What this trial is testing

Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women

Who this might be right for
Obesity
Regeneron Pharmaceuticals
Not applicableStudy completedNCT01400724
What this trial is testing

Inofolic NRT and the Metabolic Syndrome

Who this might be right for
Metabolic SyndromePostmenopausal Disorder
University of Messina 80
Not applicableNot Yet RecruitingNCT07314827
What this trial is testing

Women's Healthy Aging and Menopause; (WHAM)

Who this might be right for
MeditationHealth Education
University of Miami 60
Large-scale testing (Phase 3)Study completedNCT00522873
What this trial is testing

Endometrial Safety Study

Who this might be right for
Postmenopause
Bayer 662
Testing effectiveness (Phase 2)Study completedNCT02273973
What this trial is testing

Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)

Who this might be right for
Breast Cancer
Genentech, Inc. 334
Testing effectiveness (Phase 2)Study completedNCT00049062
What this trial is testing

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The University of Texas Health Science Center at San Antonio
Large-scale testing (Phase 3)Study completedNCT03432533
What this trial is testing

A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis

Who this might be right for
Post-Menopausal Osteoporosis
Amgen 283
Large-scale testing (Phase 3)Study completedNCT00420940
What this trial is testing

The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause

Who this might be right for
Bone DensityOsteopeniaOsteoporosis+1 more
University Health Network, Toronto 202
Testing effectiveness (Phase 2)Study completedNCT00634634
What this trial is testing

Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Rutgers, The State University of New Jersey 52
Not applicableStudy completedNCT01192893
What this trial is testing

Role of Oxytocin in Post-menopausal Osteoporosis: Evaluation on the Population of the OPUS Cohort

Who this might be right for
Osteoporosis
Centre Hospitalier Universitaire de Nice 1,000
Post-approval studies (Phase 4)Study completedNCT00545363
What this trial is testing

Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

Who this might be right for
Postmenopausal Osteoporosis
Hoffmann-La Roche 716
Testing effectiveness (Phase 2)Study completedNCT00009659
What this trial is testing

Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause

Who this might be right for
Postmenopause
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 58
Not applicableStudy completedNCT07628790
What this trial is testing

Feasibility of Lower-Body EMS Resistance Training in Postmenopausal Women

Who this might be right for
Post MenopausalResistance ExerciseBody Composition+1 more
Seoul National University 16
Testing effectiveness (Phase 2)UnknownNCT01613560
What this trial is testing

Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy

Who this might be right for
Breast Cancer
Tao OUYANG 404
Not applicableUnknownNCT04619485
What this trial is testing

Sexual and Vaginal Health in Breast Cancer Women Receiving Aromatase Inhibitors Before and After CO2 Laser Therapy

Who this might be right for
Breast CancerGenitourinary Syndrome of Menopause
Hospital Clinic of Barcelona 84
Next Page